Diabetes technology

Twelve‐month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes

Diabet MedPublished Secondary analysis of the SENCE randomised trial

Authors' conclusion

Parents demonstrated psychosocial benefits following FBI that appeared to maintain without additional intervention. CGM-focused education with behavioural support likely helps parents of young children with type 1 diabetes reduce burden and worry in the short- and long-term.

Study context

Population
Parents of children aged 2 to <8 years with T1D
Participants
45 / 42 / 44
Comparison
Continuous glucose monitoring (CGM) + FBI vs Standard-CGM vs BGM-Crossover
  • CGM + FBIn = 45
  • Standard-CGMn = 42
  • BGM-Crossovern = 44
Primary endpoint
Changes in parental psychosocial outcomes within and between groups
Follow-up
52 weeks
Methodological detailsrandomized, crossover extension (BGM-Crossover)
  • Randomized
  • Crossover extension (BGM-Crossover)

Primary result

As reported in the abstract

Within-group change in psychosocial outcomes

BGM-Crossover: diabetes burden change, 26 to 52 weeks

Δ −6.9, 95% CI

−11.3, −2.6p = 0.003

BGM-Crossover: fear of hypoglycaemia change, 26 to 52 weeks

Δ −6.4, CI

−10.1, −2.6p = 0.002

BGM-Crossover: technology satisfaction change, 26 to 52 weeks

Δ 7.3, CI

2.4, 12.2p = 0.005

Standard-CGM: technology satisfaction increase, baseline to 52 weeks

Δ 7.3, CI

0.6, 14.0p = 0.027

Original publication

Twelve‐month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes. Diabet Med. Published 2 May 2023. doi:10.1111/dme.15120

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.